Vaccine Blitz hits snag as government halts Johnson & Johnson doses
Six people have developed “rare and severe blood clots” after receiving the Johnson & Johnson coronavirus vaccine. In response, the US Centers for Disease Control and Prevention and the US Food and Drug Administration recommended suspension of all J&J vaccinations on Tuesday — a recommendation Gov. Gavin Newsom says the state will heed.
The decision was made out of “an abundance of caution” pending further review. But it could have a lasting impact on the vaccine rollout. While J&J accounts for just 4% of the state’s vaccines, there’s a psychological element at play. Some people were just shedding their vaccine skepticism when the news broke. There may be increased concerns that the federal approval process was rushed.
For reference, the number of blood clots experienced by J&J recipients is equivalent to about one in 1 million people. All of the patients were women between the ages of 18 and 48. One has died and another is in critical condition.
Unlike the Pfizer and Moderna vaccines, J&J is a single dose, making it a convenient option for many.
Read more about the pause on J&J vaccinations here.